Skip to content

Debt-to-assets at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
0.2×+0.1×
ALN
Alnylam PharmaceuticalsALNY
0.1×0.0×
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
0.3×+0.2×
Beam Therapeutics logo
Beam TherapeuticsBEAM
0.2×+0.1×
Vera Therapeutics logo
Vera TherapeuticsVERA
0.1×0.0×
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
0.0×

Other financials

Income statement

See full
Revenue$15.0M-9.5%
Operating income-$100.5M+16.8%
Net income-$96.2M+15.8%
EPS (diluted)-$0.81+26.4%

Balance sheet

See full
Cash & equivalents$134.7M+6.2%
Total debt$80.5M-32.5%
Total equity$620.9M-20.4%
Total assets$758.8M-23.1%

Cash flow

See full
Operating cash flow-$117.3M+21.2%
CapEx$79.0K-89.3%
Free cash flow-$117.4M+21.5%

Valuation

See full
Market cap$2.13B+106%
Enterprise value$2.08B+100%
P/S32.2×+9.5×

Profitability

See full
Operating margin-636.6%-202pp
Net margin-597%-194pp
FCF margin-550.2%-140pp

Returns & leverage

See full
Return on equity-56.3%-1.5pp
Debt / equity0.1×0.0×
Current ratio6.1×+1.2×

Where this comes from

Calculated from Intellia Therapeutics’s reported figures.

Based on the most recent quarter.

The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Intellia Therapeutics's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Intellia Therapeutics's debt-to-assets?
Intellia Therapeutics (NTLA) reported debt-to-assets of 0.1× in Q1 2026.
How has Intellia Therapeutics's debt-to-assets changed year-over-year?
Intellia Therapeutics's debt-to-assets decreased by 12.2% year-over-year, from 0.1× to 0.1×.
What is the long-term trend for Intellia Therapeutics's debt-to-assets?
Over 5 years (2020 to 2025), Intellia Therapeutics's debt-to-assets has grown at a 13.8% compound annual growth rate (CAGR), from 0.1× to 0.1×.
What does debt-to-assets mean?
Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.